|
|
Article: invivodata's Electronic Patient Diary Is Selected To Capture Patient Reported Outcomes Data in Cephalon Sleep Disorder Trials.
- Article from:
- Business Wire
- Article date:
- August 23, 2004
|
Copyright informationCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PITTSBURGH -- eDiary Captures Primary Efficacy Data in Four International Clinical Trials
invivodata(R) inc., an industry leader in electronic patient self-report solutions for clinical research, today announced that Cephalon Inc., a West Chester, Penn.-based global biopharmaceutical company, is using DiaryPRO(TM), invivodata's eDiary system, to collect pivotal Patient Reported Outcomes (PRO) data in four Phase III clinical trials of armodafinil. More than 200 clinical sites worldwide, including those in Eastern Europe and the Pacific Rim region, are enrolling more than 1,000 patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea ...
Related newspaper, magazine, and journal articles:
|